By: IPP Bureau
Last updated : July 18, 2025 8:49 pm
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
Concord Biotech Limited has announced the successful completion of the European Union Good Manufacturing Practice (EU GMP) inspection at our Active Pharmaceutical Ingredient (API) manufacturing facility located in Dholka, Gujarat. The inspection was conducted from July 14, 2025 to July 18, 2025.
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of our operations. It reflects our dedication to excellence and our continued focus on meeting the rigorous requirements of global regulatory authorities.